TP04HN106
Asset
Investigational therapy for the treatment of amyotrophic lateral sclerosis
- Stage
- Phase 1
- Modality
- Other
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Amyotrophic lateral sclerosis
Phase 1, Recruiting, NCT06726577, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.